Horizon Blue Cross Blue Shield of New Jersey prior authorization criteria
Submission criteria, documentation packets, and P2P prep by drug — for prescribers and PA staff. 30-day standard PA decision.
Horizon Blue Cross Blue Shield of New Jersey reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal. Criteria by drug below.
Prior authorization criteria by drug
Each page covers Horizon Blue Cross Blue Shield of New Jersey's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Horizon Blue Cross Blue Shield of New Jersey →
- Aflibercept at Horizon Blue Cross Blue Shield of New Jersey →
- Apixaban at Horizon Blue Cross Blue Shield of New Jersey →
- Atezolizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Atogepant at Horizon Blue Cross Blue Shield of New Jersey →
- Benralizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Bevacizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Bictegravir at Horizon Blue Cross Blue Shield of New Jersey →
- Buprenorphine at Horizon Blue Cross Blue Shield of New Jersey →
- Dapagliflozin at Horizon Blue Cross Blue Shield of New Jersey →
- Dulaglutide at Horizon Blue Cross Blue Shield of New Jersey →
- Dupilumab at Horizon Blue Cross Blue Shield of New Jersey →
- Eculizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Elexacaftor Tezacaftor Ivacaftor at Horizon Blue Cross Blue Shield of New Jersey →
- Empagliflozin at Horizon Blue Cross Blue Shield of New Jersey →
- Erenumab at Horizon Blue Cross Blue Shield of New Jersey →
- Evolocumab at Horizon Blue Cross Blue Shield of New Jersey →
- Faricimab at Horizon Blue Cross Blue Shield of New Jersey →
- Fingolimod at Horizon Blue Cross Blue Shield of New Jersey →
- Fremanezumab at Horizon Blue Cross Blue Shield of New Jersey →
- Galcanezumab at Horizon Blue Cross Blue Shield of New Jersey →
- Glecaprevir Pibrentasvir at Horizon Blue Cross Blue Shield of New Jersey →
- Guselkumab at Horizon Blue Cross Blue Shield of New Jersey →
- Ibrutinib at Horizon Blue Cross Blue Shield of New Jersey →
- Imatinib at Horizon Blue Cross Blue Shield of New Jersey →
- Inclisiran at Horizon Blue Cross Blue Shield of New Jersey →
- Infliximab at Horizon Blue Cross Blue Shield of New Jersey →
- Ixekizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Lenalidomide at Horizon Blue Cross Blue Shield of New Jersey →
- Liraglutide at Horizon Blue Cross Blue Shield of New Jersey →
- Lisdexamfetamine at Horizon Blue Cross Blue Shield of New Jersey →
- Mepolizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Methylphenidate at Horizon Blue Cross Blue Shield of New Jersey →
- Naltrexone at Horizon Blue Cross Blue Shield of New Jersey →
- Natalizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Nintedanib at Horizon Blue Cross Blue Shield of New Jersey →
- Nivolumab at Horizon Blue Cross Blue Shield of New Jersey →
- Nusinersen at Horizon Blue Cross Blue Shield of New Jersey →
- Ocrelizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Ofatumumab at Horizon Blue Cross Blue Shield of New Jersey →
- Omalizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Ozanimod at Horizon Blue Cross Blue Shield of New Jersey →
- Palbociclib at Horizon Blue Cross Blue Shield of New Jersey →
- Pembrolizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Pirfenidone at Horizon Blue Cross Blue Shield of New Jersey →
- Ribociclib at Horizon Blue Cross Blue Shield of New Jersey →
- Rimegepant at Horizon Blue Cross Blue Shield of New Jersey →
- Risankizumab at Horizon Blue Cross Blue Shield of New Jersey →
- Rituximab at Horizon Blue Cross Blue Shield of New Jersey →
- Rivaroxaban at Horizon Blue Cross Blue Shield of New Jersey →
- Sacubitril Valsartan at Horizon Blue Cross Blue Shield of New Jersey →
- Secukinumab at Horizon Blue Cross Blue Shield of New Jersey →
- Semaglutide at Horizon Blue Cross Blue Shield of New Jersey →
- Sofosbuvir at Horizon Blue Cross Blue Shield of New Jersey →
- Tafamidis at Horizon Blue Cross Blue Shield of New Jersey →
- Tenofovir Alafenamide at Horizon Blue Cross Blue Shield of New Jersey →
- Tezepelumab at Horizon Blue Cross Blue Shield of New Jersey →
- Tirzepatide at Horizon Blue Cross Blue Shield of New Jersey →
- Tofacitinib at Horizon Blue Cross Blue Shield of New Jersey →
- Trastuzumab at Horizon Blue Cross Blue Shield of New Jersey →
- Upadacitinib at Horizon Blue Cross Blue Shield of New Jersey →
- Ustekinumab at Horizon Blue Cross Blue Shield of New Jersey →
Generate a Horizon Blue Cross Blue Shield of New Jersey PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Horizon Blue Cross Blue Shield of New Jersey's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com